CD8A and infection: Whitney et al. explored the use of N-803 [IL-15 superagonist that has been shown to increase NK and CD8 T cells in the peripheral blood as well as SHIV-specific CD8 T cells in lymphoid follicles (78–80)] in combination with 3BNC117 and 10-1074 in macaques on ART for chronic SHIVAD8 infection.